Indication for Y Chromosome Microdeletion Analysis in Infertile Men: Is a New Sperm Concentration Threshold Needed?


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
12 2020
Historique:
received: 10 06 2020
revised: 11 09 2020
accepted: 21 09 2020
pubmed: 9 10 2020
medline: 4 2 2022
entrez: 8 10 2020
Statut: ppublish

Résumé

To describe the prevalence of Y-chromosome deletions in patients with a sperm concentration of less than 5 million/mL. To also determine a new sperm threshold for Y-chromosome analysis in men with infertility. A total of 3023 patients who had a semen concentration of less than 5 million/mL included in this retrospective study. All of these patients had a genetic evaluation, hormonal evaluation, and 2 abnormal semen analyses. Y-chromosome deletions were present in 116 (3.8 %) patients with sperm concentration <5 million/mL. The frequency of a Y-chromosome deletions was 6.8%, 1.0%, 0.15% in azoospermic men, in men with sperm concentrations of 0-1 million /mL, in men with sperm concentrations of 1-5 million/mL. Patients were divided into 2 groups regarding the determined new sperm threshold. The sensitivity and specificity of the Y-chromosome deletions test were 92.2.7% and 49.3 %, 99.1%, and 22.1% in patients with azoospermia and sperm concentrations <1 million/mL, respectively. If the sperm concentration thresholds of azoospermia or <1 million/mL, are applied, the number of tests decreased to 50.5% (1442 tests) and 23.1% (643 tests), respectively. Approximately $108,150 and $48,225 would be saved if the sperm thresholds were azoospermia and <1 million/mL, respectively CONCLUSION: The current threshold of sperm concentration for Y-chromosome deletions is controversial. The new proposed sperm threshold for genetic testing of 1 million/mL would increase sensitivity and more cost-effective compared to the current threshold.

Identifiants

pubmed: 33031841
pii: S0090-4295(20)31190-0
doi: 10.1016/j.urology.2020.09.032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-117

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Mazhar Ortac (M)

Istanbul University, Istanbul Faculty of Medicine, Urology Department, Istanbul, Turkey. Electronic address: mazhar.ortac@istanbul.edu.tr.

Rifat Ergul (R)

Istanbul University, Istanbul Faculty of Medicine, Urology Department, Istanbul, Turkey.

Mehmet Gurcan (M)

Istanbul University, Istanbul Faculty of Medicine, Urology Department, Istanbul, Turkey.

Tugba Kalayci (T)

Istanbul University, Istanbul Faculty of Medicine, Internal Medicine Department, Medical Genetics Division, Istanbul, Turkey.

Sukru Palanduz (S)

Istanbul University, Istanbul Faculty of Medicine, Internal Medicine Department, Medical Genetics Division, Istanbul, Turkey.

Resat Aydin (R)

Istanbul University, Istanbul Faculty of Medicine, Urology Department, Istanbul, Turkey.

Ateş Kadıoğlu (A)

Istanbul University, Istanbul Faculty of Medicine, Urology Department, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH